Compare AJANTA PHARMA with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA J.B.CHEMICALS AJANTA PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 24.7 37.7 65.4% View Chart
P/BV x 6.9 7.0 97.7% View Chart
Dividend Yield % 0.5 0.2 306.8%  

Financials

 AJANTA PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
J.B.CHEMICALS
Mar-18
AJANTA PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs1,422363 391.6%   
Low Rs898255 352.0%   
Sales per share (Unadj.) Rs233.5169.1 138.1%  
Earnings per share (Unadj.) Rs44.016.6 264.9%  
Cash flow per share (Unadj.) Rs52.223.4 222.7%  
Dividends per share (Unadj.) Rs9.002.00 450.0%  
Dividend yield (eoy) %0.80.6 119.9%  
Book value per share (Unadj.) Rs255.1172.5 147.9%  
Shares outstanding (eoy) m88.0283.57 105.3%   
Bonus/Rights/Conversions BBBB-  
Price / Sales ratio x5.01.8 271.8%   
Avg P/E ratio x26.418.6 141.7%  
P/CF ratio (eoy) x22.213.2 168.5%  
Price / Book Value ratio x4.51.8 253.8%  
Dividend payout %20.512.0 169.9%   
Avg Mkt Cap Rs m102,08125,827 395.2%   
No. of employees `0006.83.8 180.3%   
Total wages/salary Rs m4,3072,511 171.5%   
Avg. sales/employee Rs Th3,022.63,747.4 80.7%   
Avg. wages/employee Rs Th633.4665.7 95.1%   
Avg. net profit/employee Rs Th569.1367.8 154.7%   
INCOME DATA
Net Sales Rs m20,55414,135 145.4%  
Other income Rs m211366 57.6%   
Total revenues Rs m20,76514,501 143.2%   
Gross profit Rs m5,6642,178 260.0%  
Depreciation Rs m721570 126.5%   
Interest Rs m1235 33.2%   
Profit before tax Rs m5,1431,940 265.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273552 230.5%   
Profit after tax Rs m3,8701,387 279.0%  
Gross profit margin %27.615.4 178.8%  
Effective tax rate %24.828.5 86.9%   
Net profit margin %18.89.8 191.8%  
BALANCE SHEET DATA
Current assets Rs m11,81210,470 112.8%   
Current liabilities Rs m3,7762,749 137.4%   
Net working cap to sales %39.154.6 71.6%  
Current ratio x3.13.8 82.1%  
Inventory Days Days7755 140.2%  
Debtors Days Days8278 105.1%  
Net fixed assets Rs m14,3985,811 247.8%   
Share capital Rs m175167 105.0%   
"Free" reserves Rs m22,27714,248 156.3%   
Net worth Rs m22,45214,416 155.7%   
Long term debt Rs m70-   
Total assets Rs m26,96217,649 152.8%  
Interest coverage x444.356.6 785.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 95.2%   
Return on assets %14.48.1 178.7%  
Return on equity %17.29.6 179.1%  
Return on capital %23.013.7 167.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,6826,164 173.3%   
Fx outflow Rs m2,1021,334 157.5%   
Net fx Rs m8,5804,829 177.7%   
CASH FLOW
From Operations Rs m3,7481,231 304.6%  
From Investments Rs m-2,228-208 1,070.6%  
From Financial Activity Rs m-1,475-595 247.7%  
Net Cashflow Rs m45427 10.6%  

Share Holding

Indian Promoters % 73.8 55.4 133.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 1.6 3.4 45.7%  
FIIs % 7.6 3.9 194.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 37.0 45.9%  
Shareholders   20,968 30,437 68.9%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON   IPCA LABS  JUBILANT PHARMOVA   

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat, GAIL and UPL Among Top Nifty Gainers(Closing)

Indian share markets continued their volatile trend during closing hours today and ended their day on a flat note.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Mar 8, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS